TLCD1 and metabolic dysfunction-associated steatohepatitis: Altogether, these results reveal that Tlcd1/2 deletion reduces the severity of NASH in mice in a sex-specific manner, with decreased liver damage and fibrosis observed in males, while a more prominent suppression of liver inflammation was found in females.